ÂÜÀòÂÒÂ×

Dr. Peter Renehan is an Observer to the Board of Directors at Anthos Therapeutics. Dr. Renehan is a Principal on the Blackstone Life Sciences team. He was previously an investment banking Associate in Lazard’s San Francisco office, where he focused on biopharma mergers and acquisitions. His experience prior to Lazard includes working in corporate strategy at Moderna Therapeutics and Flagship Pioneering. Dr. Renehan graduated with dual MD/MBA degrees from Harvard University and was a Fulbright Scholar in Indonesia.